These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 1100957)

  • 21. Can leprosy be eradicated with chemotherapy? An evaluation of the Malta Leprosy Eradication Project.
    Jacobson RR; Gatt P
    Lepr Rev; 2008 Dec; 79(4):410-5. PubMed ID: 19274987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Drug resistance of Mycobacterium leprae].
    Pattyn SR
    Acta Leprol; 1986; 4(3):279-87. PubMed ID: 3551466
    [No Abstract]   [Full Text] [Related]  

  • 23. Dapsone drug resistance in the MDT era.
    Roche PW; Neupane KD; Failbus SS; Butlin CR
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
    [No Abstract]   [Full Text] [Related]  

  • 24. Combined therapy in leprosy. Background and findings.
    Freerksen E; Rosenfeld M; Bonnici E; Depasquale G; Kriiger-Thiemer M
    Chemotherapy; 1978; 24(3):187-201. PubMed ID: 657879
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Concepts behind the development of multiple drug therapy regimens in leprosy.
    Waters MF
    Lepr Rev; 1986 Dec; 57 Suppl 1():61-7. PubMed ID: 3295437
    [No Abstract]   [Full Text] [Related]  

  • 26. [Clinical and bacteriological assessment 8 years after triple-drug therapy for multibacillary leprosy in Senegal].
    Dousset-Faure I; Millan J; Decazes JM; Languillon J
    Acta Leprol; 1986; 4(4):465-72. PubMed ID: 3296618
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Comparative study of the treatment of pulmonary tuberculosis with isoprodian and pyrazinamide as well as isoprodian and rifampicin].
    Sighart H; Opl G; Weirich H
    Wien Med Wochenschr; 1982 Nov; 132(22):559-61. PubMed ID: 7168180
    [No Abstract]   [Full Text] [Related]  

  • 28. Multi-drug therapy in leprosy: an effective method of control.
    Indian J Lepr; 1984; 56(1):102-12. PubMed ID: 6548238
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The chemotherapy of leprosy. Part 1.
    Ellard GA
    Int J Lepr Other Mycobact Dis; 1990 Dec; 58(4):704-16. PubMed ID: 2280120
    [No Abstract]   [Full Text] [Related]  

  • 30. In vitro and in vivo effects of N-methyl-3,5-dichloro-benzylamine hydrochloride on Mycobacterium leprae.
    Dhople AM; Strong LC; Meindl W; Schoenenberger H; Gardner GD
    Arzneimittelforschung; 1991 Mar; 41(3):253-6. PubMed ID: 1867663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug resistance in leprosy: lessons from past and future perspective.
    Gupta UD; Katoch VM
    Indian J Lepr; 1999; 71(4):451-63. PubMed ID: 10804973
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relapse with multibacillary leprosy caused by rifampicin sensitive organisms following paucibacillary multidrug therapy.
    Soares DJ; Neupane K; Britton WJ
    Lepr Rev; 1995 Sep; 66(3):210-3. PubMed ID: 7500815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rifampicin: the investigation of a bactericidal antileprosy drug.
    Rees RJ
    Lepr Rev; 1975 Jun; 46(2 Suppl):121-4. PubMed ID: 1100951
    [No Abstract]   [Full Text] [Related]  

  • 34. [The Malta project (a program for the eradication of leprosy)].
    Freerksen E; Rosenfeld M; Despasquale G; Bonnici E
    Acta Leprol; 1988; 6(5):7-46. PubMed ID: 3078224
    [No Abstract]   [Full Text] [Related]  

  • 35. New forms of multidrug therapy for the treatment of leprosy. First report for the practice on rifampicin + sulfamethoxazole-trimethoprim + protionamide and rifampicin + sulfamethoxazole-trimethoprim + isoniazid.
    Freerksen E; Rosenfeld M; Spannuth G
    Chemotherapy; 1989; 35(2):133-9. PubMed ID: 2758869
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical results obtained with Isoprodian in the treatment of new cases of pulmonary tuberculosis.
    Sighart H
    Scand J Respir Dis Suppl; 1978; 102():60-1. PubMed ID: 356259
    [No Abstract]   [Full Text] [Related]  

  • 37. Polytherapy in multibacillary leprosy patients in Nepal.
    Samuel NM; Samual S; Fairbairn T; Adiga RB
    Singapore Med J; 1985 Apr; 26(2):203-6. PubMed ID: 4035403
    [No Abstract]   [Full Text] [Related]  

  • 38. THELEP controlled clinical trials in lepromatous leprosy.
    Lepr Rev; 1983 Sep; 54(3):167-76. PubMed ID: 6355720
    [No Abstract]   [Full Text] [Related]  

  • 39. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy.
    Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT
    Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-term treatment of dapsone-resistant leprosy with rifampicin: clinical and bacteriological studies.
    Rees RJ; Waters MF; Pearson JM; Helmy HS; Laing AB
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):159-69. PubMed ID: 776852
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.